Experienced in Menopause

Ying K. Zhong

Yangzhou, CN 
Experienced in Menopause
Yangzhou, CN 
OverviewLocationsClinical Research

Overview

Ying Zhong practices in Yangzhou, China. Ms. Zhong is rated as an Experienced expert by MediFind in the treatment of Menopause. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Nasopharyngeal Carcinoma, Osteoporosis, and Mastectomy.

Her clinical research consists of co-authoring 89 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Menopause.

Gender
Female

Locations

Yangzhou, 225009, China
Other Locations
Nanchang, China
Chongqing, 400065, China
Key Laboratory Of Molecular Pharmacology And Drug Evaluation, Yantai, China
Shenzhen, China
Guangdong Provincial Key Laboratory Of Malignant Tumor Epigenetics And Gene Regulation, Guangzhou, China
Xiangtan, China
No. 57, Renmin Avenue South, Zhangjian City, Xiashan, 524001, China
Peking Union Medical College Hospital, Peking Union Medical College, Beijing, 100730, China
Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Wangfujing, 100730, China
Zhanjiang, 524001, China
Wailong, 999078, China
Changsha, China
State Key Laboratory Of Precision Measurement Technology And Instruments, Tianjin, 300072, China
Department Of Otolaryngology Head And Neck Surgery, Zhuhai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

88 Total Publications

Comparison of anlotinib combined with docetaxel versus single docetaxel as second-line treatment beside radiotherapy for advanced non-small cell lung cancer: Efficacy and safety.
Comparison of anlotinib combined with docetaxel versus single docetaxel as second-line treatment beside radiotherapy for advanced non-small cell lung cancer: Efficacy and safety.
Journal: Pakistan journal of pharmaceutical sciences
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Zhong's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile